Other
heparin lock
heparin lock is an intervention with 3 clinical trials. Historical success rate of 33.3%.
Total Trials
3
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
33.3%
Based on 1 completed trials
Completion Rate
33%(1/3)
Active Trials
0(0%)
Results Posted
200%(2 trials)
Terminated
2(67%)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
33.3%
1 of 3 finished
Non-Completion Rate
66.7%
2 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(1)
Terminated(2)
Detailed Status
Terminated2
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
33.3%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
terminated267%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
terminatednot_applicable
Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections
NCT02890875
terminatedphase_1
Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition
NCT02227329
completednot_applicable
Pediatric Ethanol Lock Therapy Study.
NCT00948441
Clinical Trials (3)
Showing 3 of 3 trials
NCT02890875Not Applicable
Efficacy and Safety of Ethanol Lock Therapy for the Prevention of Central Line-associated Bloodstream Infections
NCT02227329Phase 1
Prophylactic Ethanol Lock Therapy (ELT) in Patients on Home Parenteral Nutrition
NCT00948441Not Applicable
Pediatric Ethanol Lock Therapy Study.
All 3 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 3